FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Michele Magni

Research Profile

Chemicals & Drugs

Anatomy

Procedures

Co-author Network

Publications

TOP 3
Michele Magni; Paola Matteucci; Fernando Ravagnani; Massimo Di Nicola; Carmelo Carlo-Stella; liliana devizzi; Anna Guidetti; Alessandro M Gianni
Detection of minimal residual disease in hematopoietic progenitor cell harvests: lack of predictive value of peripheral blood and bone marrow analysis in mantle cell and indolent lymphoma.
Roberta Zappasodi; Italia Bongarzone; Antonello Cabras; Carmelo Carlo-Stella; Lorenzo Castagnoli; Gaia C Ghedini; Alessandro M Gianni; Michele Magni; Antonella Messina; Serenella M Pupa; Monica Tortoreto; Claudio Tripodo; Massimo Di Nicola
Serological identification of HSP105 as a novel non-Hodgkin lymphoma therapeutic target.
Simonetta Viviani; Massimo Di Nicola; Valeria Bonfante; Antonio Di Stasi; Carmelo Carlo-Stella; Paola Matteucci; Michele Magni; liliana devizzi; Pinuccia Valagussa; ALESSANDRO MASSIMO GIANNI
Long-term results of high-dose chemotherapy with autologous bone marrow or peripheral stem cell transplant as first salvage treatment for relapsed or refractory Hodgkin lymphoma: a single institution experience.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Michele Magni (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Michele Magni; Paola Matteucci; Fernando Ravagnani; Massimo Di Nicola; Carmelo Carlo-Stella; liliana devizzi; Anna Guidetti; Alessandro M Gianni
Detection of minimal residual disease in hematopoietic progenitor cell harvests: lack of predictive value of peripheral blood and bone marrow analysis in mantle cell and indolent lymphoma.
American journal of blood research 2012;2(2):105-12.
2011: Roberta Zappasodi; Italia Bongarzone; Antonello Cabras; Carmelo Carlo-Stella; Lorenzo Castagnoli; Gaia C Ghedini; Alessandro M Gianni; Michele Magni; Antonella Messina; Serenella M Pupa; Monica Tortoreto; Claudio Tripodo; Massimo Di Nicola
Serological identification of HSP105 as a novel non-Hodgkin lymphoma therapeutic target.
Blood 2011;118(16):4421-30.
2010: Simonetta Viviani; Massimo Di Nicola; Valeria Bonfante; Antonio Di Stasi; Carmelo Carlo-Stella; Paola Matteucci; Michele Magni; liliana devizzi; Pinuccia Valagussa; ALESSANDRO MASSIMO GIANNI
Long-term results of high-dose chemotherapy with autologous bone marrow or peripheral stem cell transplant as first salvage treatment for relapsed or refractory Hodgkin lymphoma: a single institution experience.
Leukemia & lymphoma 2010;51(7):1251-9.
2010: Michele Magni; Massimo Di Nicola; Carmelo Carlo-Stella; liliana devizzi; Anna Guidetti; Paola Matteucci; ALESSANDRO MASSIMO GIANNI
Efficacy and safety of high-dose chemotherapy with in vivo purged auto-SCT in relapsed follicular lymphoma: long-term follow-up.
Bone marrow transplantation 2010;45(6):1119-20.
2010: Cristiana Lavazza; Carmelo Carlo-Stella; Arianna Giacomini; Loredana Cleris; Marco Righi; Daniela Sia; Massimo Di Nicola; Michele Magni; Paolo Longoni; Marco Milanesi; Maura Francolini; Annunziata Gloghini; Antonino Carbone; Franca Formelli; ALESSANDRO MASSIMO GIANNI
Human CD34+ cells engineered to express membrane-bound tumor necrosis factor-related apoptosis-inducing ligand target both tumor cells and tumor vasculature.
Blood 2010;115(11):2231-40.
2009: Michele Magni; Massimo Di Nicola; Carmelo Carlo-Stella; Paola Matteucci; liliana devizzi; Corrado Tarella; Fabio Benedetti; Maurizio Martelli; Caterina Patti; Guido Parvis; Alessandro Rambaldi; T Barbui; ALESSANDRO MASSIMO GIANNI
High-dose sequential chemotherapy and in vivo rituximab-purged stem cell autografting in mantle cell lymphoma: a 10-year update of the R-HDS regimen.
Bone marrow transplantation 2009;43(6):509-11.
2009: Massimo Di Nicola; Roberta Zappasodi; Carmelo Carlo-Stella; Roberta Mortarini; Serenella M Pupa; Michele Magni; liliana devizzi; Paola Matteucci; Paola Baldassari; Fernando Ravagnani; Antonello Cabras; Andrea Anichini; ALESSANDRO MASSIMO GIANNI
Vaccination with autologous tumor-loaded dendritic cells induces clinical and immunologic responses in indolent B-cell lymphoma patients with relapsed and measurable disease: a pilot study.
Blood 2009;113(1):18-27.
2007: Corrado Tarella; Manuela Zanni; Massimo Di Nicola; Caterina Patti; Roberta Calvi; Alessandra Pescarollo; Valerio Zoli; A Fornari; Domenico Novero; Antonello Cabras; M Stella; A Comino; Daniele Remotti; Maurilio Ponzoni; Daniele Caracciolo; marco ladetto; Michele Magni; liliana devizzi; Rosalba Rosato; Mario Boccadoro; Marco Bregni; Paolo Corradini; Andrea Gallamini; Ignazio Majolino; Salvatore Mirto; ALESSANDRO MASSIMO GIANNI
Prolonged survival in poor-risk diffuse large B-cell lymphoma following front-line treatment with rituximab-supplemented, early-intensified chemotherapy with multiple autologous hematopoietic stem cell support: a multicenter study by GITIL (Gruppo Italiano Terapie Innovative nei Linfomi).
Leukemia 2007;21(8):1802-11.
2007: Cristiana Lavazza; Carmelo Carlo-Stella; Massimo Di Nicola; Paolo Longoni; Marco Milanesi; Michele Magni; ALESSANDRO MASSIMO GIANNI
Highly efficient gene transfer into mobilized CD34+ hematopoietic cells using serotype-5 adenoviral vectors and BoosterExpress Reagent.
Experimental hematology 2007;35(6):888-97.
2007: Carmelo Carlo-Stella; Anna Guidetti; Massimo Di Nicola; Cristiana Lavazza; Loredana Cleris; Daniela Sia; Paolo Longoni; Marco Milanesi; Michele Magni; Zoltan Nagy; Paolo Corradini; Antonino Carbone; Franca Formelli; ALESSANDRO MASSIMO GIANNI
IFN-gamma enhances the antimyeloma activity of the fully human anti-human leukocyte antigen-DR monoclonal antibody 1D09C3.
Cancer research 2007;67(7):3269-75.
2007: Carmelo Carlo-Stella; Massimo Di Nicola; Paolo Longoni; Loredana Cleris; Cristiana Lavazza; Raffaella Milani; Marco Milanesi; Michele Magni; Virgilio Pace; Francesco Colotta; Maria A Avanzini; Franca Formelli; ALESSANDRO MASSIMO GIANNI
Placental growth factor-1 potentiates hematopoietic progenitor cell mobilization induced by granulocyte colony-stimulating factor in mice and nonhuman primates.
Stem cells (Dayton, Ohio) 2007;25(1):252-61.
2006: marco ladetto; Michele Magni; Gloria Pagliano; Federica De Marco; Daniela Drandi; Irene Ricca; Monica Astolfi; Paola Matteucci; Anna Guidetti; Barbara Mantoan; Chiara Lobetti Bodoni; Manuela Zanni; Mario Boccadoro; ALESSANDRO MASSIMO GIANNI; Corrado Tarella
Rituximab induces effective clearance of minimal residual disease in molecular relapses of mantle cell lymphoma.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2006;12(12):1270-6.
2006: Vittorio Perfetti; Salvatore Siena; Giovanni Palladini; Marco Bregni; Massimo Di Nicola; Laura Obici; Michele Magni; Laura Brunetti; ALESSANDRO MASSIMO GIANNI; Giampaolo Merlini
Long-term results of a risk-adapted approach to melphalan conditioning in autologous peripheral blood stem cell transplantation for primary (AL) amyloidosis.
Haematologica 2006;91(12):1635-43.
2006: Carmelo Carlo-Stella; Cristiana Lavazza; Massimo Di Nicola; Loredana Cleris; Paolo Longoni; Marco Milanesi; Michele Magni; Daniele Morelli; Annunziata Gloghini; Antonino Carbone; ALESSANDRO MASSIMO GIANNI
Antitumor activity of human CD34+ cells expressing membrane-bound tumor necrosis factor-related apoptosis-inducing ligand.
Human gene therapy 2006;17(12):1225-40.
2006: Paola Matteucci; Carmelo Carlo-Stella; Massimo Di Nicola; Michele Magni; Anna Guidetti; Maddalena Marchesi; ALESSANDRO MASSIMO GIANNI
Topical prophylaxis of conjunctivitis induced by high-dose cytosine arabinoside.
Haematologica 2006;91(2):255-7.
2006: Carmelo Carlo-Stella; Massimo Di Nicola; Maria Caterina Turco; Loredana Cleris; Cristiana Lavazza; Paolo Longoni; Marco Milanesi; Michele Magni; Massimo Ammirante; Arturo Leone; Zoltan Nagy; Walter R Gioffrè; Franca Formelli; ALESSANDRO MASSIMO GIANNI
The anti-human leukocyte antigen-DR monoclonal antibody 1D09C3 activates the mitochondrial cell death pathway and exerts a potent antitumor activity in lymphoma-bearing nonobese diabetic/severe combined immunodeficient mice.
Cancer research 2006;66(3):1799-808.
2004: Massimo Di Nicola; Carmelo Carlo-Stella; Jacopo Mariotti; liliana devizzi; maura massimino; Antonello Cabras; Michele Magni; Paola Matteucci; Anna Guidetti; Lorenza Gandola; ALESSANDRO MASSIMO GIANNI
High response rate and manageable toxicity with an intensive, short-term chemotherapy programme for Burkitt's lymphoma in adults.
British journal of haematology 2004;126(6):815-20.
2004: Massimo Di Nicola; Carmelo Carlo-Stella; Roberta Mortarini; Paola Baldassari; Anna Guidetti; Gianfrancesco Gallino; Michele Del Vecchio; Fernando Ravagnani; Michele Magni; Paul Chaplin; Natale Cascinelli; Giorgio Parmiani; ALESSANDRO MASSIMO GIANNI; Andrea Anichini
Boosting T cell-mediated immunity to tyrosinase by vaccinia virus-transduced, CD34(+)-derived dendritic cell vaccination: a phase I trial in metastatic melanoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(16):5381-90.
2004: Carmelo Carlo-Stella; Massimo Di Nicola; Raffaella Milani; Anna Guidetti; Michele Magni; Marco Milanesi; Paolo Longoni; Paola Matteucci; Franca Formelli; Fernando Ravagnani; Paolo Corradini; ALESSANDRO MASSIMO GIANNI
Use of recombinant human growth hormone (rhGH) plus recombinant human granulocyte colony-stimulating factor (rhG-CSF) for the mobilization and collection of CD34+ cells in poor mobilizers.
Blood 2004;103(9):3287-95.
2004: Carmelo Carlo-Stella; Massimo Di Nicola; Paolo Longoni; Raffaella Milani; Marco Milanesi; Anna Guidetti; Krista G Haanstra; margreet jonker; Loredana Cleris; Michele Magni; Franca Formelli; ALESSANDRO MASSIMO GIANNI
Mobilization of primitive and committed hematopoietic progenitors in nonhuman primates treated with defibrotide and recombinant human granulocyte colony-stimulating factor.
Experimental hematology 2004;32(1):68-75.
2003: Massimo Di Nicola; Sara Napoli; Andrea Anichini; Roberta Mortarini; Luca Romagnoli; Michele Magni; Paola Matteucci; Paola Baldassarri; Ilaria Bersani; Carmelo Carlo-Stella; ALESSANDRO MASSIMO GIANNI
Dendritic cell viability is decreased after phagocytosis of apoptotic tumor cells induced by staurosporine or vaccinia virus infection.
Haematologica 2003;88(12):1396-404.
2003: Alessandra Cuttica; Francesco Zallio; marco ladetto; Massimo Di Nicola; Daniele Caracciolo; Michele Magni; Carlo Marinone; Maria Dell'Aquila; Michela Rosace; Alessandro Pileri; Mario Boccadoro; ALESSANDRO MASSIMO GIANNI; Corrado Tarella
Patients with high-risk aggressive lymphoma treated with frontline intensive chemotherapy and autografting: evidence of marked differences in outcome between patients with age-adjusted International Prognostic Index scores 2 and 3.
Cancer 2003;98(5):983-92.
2003: ALESSANDRO MASSIMO GIANNI; Michele Magni; Maurizio Martelli; Massimo Di Nicola; Carmelo Carlo-Stella; Silvana Pilotti; Alessandro Rambaldi; Sergio Cortelazzo; Caterina Patti; Guido Parvis; Fabio Benedetti; Saveria Capria; Paolo Corradini; Corrado Tarella; Tiziano Barbui
Long-term remission in mantle cell lymphoma following high-dose sequential chemotherapy and in vivo rituximab-purged stem cell autografting (R-HDS regimen).
Blood 2003;102(2):749-55.
2002: Michele Magni; Massimo Di Nicola; Carmelo Carlo-Stella; Paola Matteucci; Cristiana Lavazza; Salvatore Grisanti; Carlo Bifulco; Silvana Pilotti; Daniela Papini; Juan Rosai; ALESSANDRO MASSIMO GIANNI
Identical rearrangement of immunoglobulin heavy chain gene in neoplastic Langerhans cells and B-lymphocytes: evidence for a common precursor.
Leukemia research 2002;26(12):1131-3.
2002: Corrado Tarella; Massimo Di Nicola; Daniele Caracciolo; Francesco Zallio; Alessandra Cuttica; Paola Omedè; P Bondesan; Michele Magni; Paola Matteucci; Andrea Gallamini; Alessandro Pileri; ALESSANDRO MASSIMO GIANNI
High-dose ara-C with autologous peripheral blood progenitor cell support induces a marked progenitor cell mobilization: an indication for patients at risk for low mobilization.
Bone marrow transplantation 2002;30(11):725-32.
2002: Carmelo Carlo-Stella; Massimo Di Nicola; Michele Magni; Paolo Longoni; Marco Milanesi; Claudio Stucchi; Loredana Cleris; Franca Formelli; ALESSANDRO MASSIMO GIANNI
Defibrotide in combination with granulocyte colony-stimulating factor significantly enhances the mobilization of primitive and committed peripheral blood progenitor cells in mice.
Cancer research 2002;62(21):6152-7.
2002: Paola Matteucci; Michele Magni; Massimo Di Nicola; Carmelo Carlo-Stella; Caterina Uberti; ALESSANDRO MASSIMO GIANNI
Leukoencephalopathy and papovavirus infection after treatment with chemotherapy and anti-CD20 monoclonal antibody.
Blood 2002;100(3):1104-5.
2002: Massimo Di Nicola; Carmelo Carlo-Stella; Michele Magni; Marco Milanesi; Paolo Longoni; Paola Matteucci; Salvatore Grisanti; ALESSANDRO MASSIMO GIANNI
Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli.
Blood 2002;99(10):3838-43.
2002: ALESSANDRO MASSIMO GIANNI; Sergio Cortelazzo; Michele Magni; M Martelli
Rituximab: enhancing stem cell transplantation in mantle cell lymphoma.
Bone marrow transplantation 2002;29 Suppl 1():S10-3.
2001: Valeria Bonfante; Simonetta Viviani; liliana devizzi; Anna Di Russo; Massimo Di Nicola; Michele Magni; Paola Matteucci; Salvatore Grisanti; Pinuccia Valagussa; Gianni Bonadonna; ALESSANDRO MASSIMO GIANNI
High-dose ifosfamide and vinorelbine as salvage therapy for relapsed or refractory Hodgkin's disease.
European journal of haematology. Supplementum 2001;64():51-5.
2000: Massimo Di Nicola; Carmelo Carlo-Stella; Marco Milanesi; Michele Magni; Paolo Longoni; Roberta Mortarini; Andrea Anichini; Rosella Tomanin; MAURIZIO SCARPA; ALESSANDRO MASSIMO GIANNI
Large-scale feasibility of gene transduction into human CD34+ cell-derived dendritic cells by adenoviral/polycation complex.
British journal of haematology 2000;111(1):344-50.
2000: Michele Magni; Massimo Di Nicola; liliana devizzi; Paola Matteucci; F Lombardi; Lorenza Gandola; Fernando Ravagnani; Roberto Giardini; G Dastoli; Corrado Tarella; Alessandro Pileri; Gianni Bonadonna; ALESSANDRO MASSIMO GIANNI
Successful in vivo purging of CD34-containing peripheral blood harvests in mantle cell and indolent lymphoma: evidence for a role of both chemotherapy and rituximab infusion.
Blood 2000;96(3):864-9.
1999: Massimo Di Nicola; Marco Milanesi; Michele Magni; Marco Bregni; Carmelo Carlo-Stella; Paolo Longoni; Rosella Tomanin; Fernando Ravagnani; MAURIZIO SCARPA; Craig T Jordan; ALESSANDRO MASSIMO GIANNI
Recombinant adenoviral vector-lipofectAMINE complex for gene transduction into human T lymphocytes.
Human gene therapy 1999;10(11):1875-84.
1999: Vittorio Perfetti; P Ubbiali; Michele Magni; M Colli Vignarelli; Simona Casarini; Paola Matteucci; ALESSANDRO MASSIMO GIANNI; Giampaolo Merlini
Cells with clonal light chains are present in peripheral blood at diagnosis and in apheretic stem cell harvests of primary amyloidosis.
Bone marrow transplantation 1999;23(4):323-7.
1999: Massimo Di Nicola; Paolo Longoni; Michele Magni; ALESSANDRO MASSIMO GIANNI
The influence of interleukin (IL)-4 and IL-13 on human dendritic cell differentiation from CD34+ progenitor cells: the importance of the source of serum.
Experimental hematology 1999;27(2):386-7.
1998: Massimo Di Nicola; Salvatore Siena; Marco Bregni; Paolo Longoni; Michele Magni; Marco Milanesi; Paola Matteucci; Roberta Mortarini; Andrea Anichini; Giorgio Parmiani; Ingo Drexler; Volker Erfle; Gerd Sutter; ALESSANDRO MASSIMO GIANNI
Gene transfer into human dendritic antigen-presenting cells by vaccinia virus and adenovirus vectors.
Cancer gene therapy 1998;5(6):350-6.
1998: Marco Bregni; S Shammah; F Malaffo; Massimo Di Nicola; Marco Milanesi; Michele Magni; Paola Matteucci; Fernando Ravagnani; Craig T Jordan; Salvatore Siena; ALESSANDRO MASSIMO GIANNI
Adenovirus vectors for gene transduction into mobilized blood CD34+ cells.
Gene therapy 1998;5(4):465-72.
1996: Massimo Di Nicola; Salvatore Siena; Paolo Corradini; Marco Bregni; Marco Milanesi; Michele Magni; P A Ruffini; Fernando Ravagnani; Corrado Tarella; ALESSANDRO MASSIMO GIANNI
Elimination of bcl-2-IgH-positive follicular lymphoma cells from blood transplants with high recovery of hematopoietic progenitors by the miltenyi CD34+ cell sorting system.
Bone marrow transplantation 1996;18(6):1117-21.
1996: Salvatore Siena; Marco Bregni; Massimo Di Nicola; Michele Magni; Fernando Ravagnani; L Gandola; F Lombardi; ALESSANDRO MASSIMO GIANNI
[Long-term hematopoietic reconstitution after myeloablative antitumor therapy and circulating hematopoietic stem cell transplantation].
Tumori 1996;82(2 Suppl):S23-7.
1996: Michele Magni; S Shammah; R Schiró; W Mellado; Riccardo Dalla-Favera; ALESSANDRO MASSIMO GIANNI
Induction of cyclophosphamide-resistance by aldehyde-dehydrogenase gene transfer.
Blood 1996;87(3):1097-103.
1994: Massimo Di Nicola; Salvatore Siena; Marco Bregni; Fernando Ravagnani; F Vitello; N Belli; A Dodero; Michele Magni; Gianni Bonadonna; ALESSANDRO MASSIMO GIANNI
Large-scale enrichment of mobilized CD34+ peripheral blood hematopoietic progenitors by removal of nylon wool-adherent mature cells.
Bone marrow transplantation 1994;14(6):863-9.
1993: Massimo Di Nicola; Salvatore Siena; Marco Bregni; Fedro Alessandro Peccatori; Michele Magni; Fernando Ravagnani; L Zorzino; Gianni Bonadonna; ALESSANDRO MASSIMO GIANNI
Quantization of CD34+ peripheral blood hematopoietic progenitors for autografting in cancer patients.
The International journal of artificial organs 1993;16 Suppl 5():80-2.
1993: ALESSANDRO MASSIMO GIANNI; Salvatore Siena; Marco Bregni; F Lombardi; L Gandola; Massimo Di Nicola; Michele Magni; Fedro Alessandro Peccatori; P Valagussa; Gianni Bonadonna
High-dose sequential chemo-radiotherapy with peripheral blood progenitor cell support for relapsed or refractory Hodgkin's disease--a 6-year update.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1993;4(10):889-91.
1993: ALESSANDRO MASSIMO GIANNI; Salvatore Siena; Marco Bregni; Massimo Di Nicola; Fedro Alessandro Peccatori; Michele Magni; Fernando Ravagnani; I Sklenar; Gianni Bonadonna
Recombinant human interleukin-3 hastens trilineage hematopoietic recovery following high-dose (7 g/m2) cyclophosphamide cancer therapy.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1993;4(9):759-66.
1993: Salvatore Siena; Marco Bregni; Laura Bonsi; Pierluigi Strippoli; Fedro Alessandro Peccatori; Michele Magni; Massimo Di Nicola; Gian Paolo Bagnara; A Massimo Gianni
Clinical implications of the heterogeneity of hematopoietic progenitors elicited in peripheral blood by anticancer therapy with cyclophosphamide and cytokine(s).
Stem cells (Dayton, Ohio) 1993;11 Suppl 2():72-5.
1992: ALESSANDRO MASSIMO GIANNI; Marco Bregni; Salvatore Siena; Michele Magni; Massimo Di Nicola; F Lombardi; Corrado Tarella; A Pileri; Gianni Bonadonna
Granulocyte-macrophage colony-stimulating factor or granulocyte colony-stimulating factor infusion makes high-dose etoposide a safe outpatient regimen that is effective in lymphoma and myeloma patients.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1992;10(12):1955-62.
1992: Marco Bregni; Michele Magni; Salvatore Siena; Massimo Di Nicola; Gianni Bonadonna; ALESSANDRO MASSIMO GIANNI
Human peripheral blood hematopoietic progenitors are optimal targets of retroviral-mediated gene transfer.
Blood 1992;80(6):1418-22.
1991: Marco Bregni; Salvatore Siena; Michele Magni; Gianni Bonadonna; ALESSANDRO MASSIMO GIANNI
Circulating hemopoietic progenitors mobilized by cancer chemotherapy and by rhGM-CSF in the treatment of high-grade non-Hodgkin's lymphoma.
Leukemia 1991;5 Suppl 1():123-7.